Inogen | INGN - Equity Capital And Reserves


Inogen reported $197.18M in Equity Capital and Reserves for its fiscal quarter ending in September of 2025.





Equity Capital And Reserves Change Date
Abbott USD 52.06B 69M Mar/2026
Accuray USD 53.42M 8.45M Dec/2025
AngioDynamics USD 176.33M 2.52M Sep/2025
Artivion USD 445.58M 4.88M Jun/2026
AtriCure USD 516.43M 24.74M Jun/2026
Baxter International USD 6.21B 163M Jun/2026
Becton, Dickinson and Co. USD 24.42B 283M Jun/2026
Boston Scientific USD 24.93B 934M Jun/2026
Cooper Companies USD 8.33B 89.1M Jun/2026
Dexcom USD 2.62B 335.5M Jun/2026
Edwards Lifesciences USD 10.62B 290.5M Jun/2026
Globus Medical USD 4.77B 36.29M Jun/2026
Inogen USD 197.18M 2.32M Sep/2025
Insulet USD 1.42B 119.6M Jun/2026
Medtronic USD 50.23B 160M Jun/2026
Orthofix International USD 429.18M 6.01M Jun/2026
Philips EUR 11.48B 84M Jun/2026
ResMed USD 6.59B 93.48M Jun/2026
Steris USD 7.21B 23.1M Jun/2026
Stryker USD 22.98B 559M Mar/2026
Tandem Diabetes Care USD 130.39M 2.02M Jun/2026
Teleflex USD 2.9B 179.9M Jun/2026
X T L Biopharmaceuticals USD -254K 207K Dec/2025
Zimmer Biomet Holdings USD 12.63B 49.1M Jun/2026